Work is underway on an EU directive to make multiple-vote share structures that allow the founders of start-ups to retain control when raising funds on public markets an option in all member states. The argument is that this will reduce reluctance to list and increase access to capital.
STOCKHOLM, April 28, 2023 /PRNewswire/ The shareholders of Calliditas Therapeutics AB (publ) ("Calliditas Therapeutics"), Reg. No. 556659-9766, with registered office in Stockholm, are summoned